Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)

Rob Riemsma; Carol A. Forbes; Mayur M. Amonkar; Konstantinos Lykopoulos; Jose R. Diaz; Jos Kleijnen; Daniel W. Rea

doi:10.1185/03007995.2012.707643

Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)

Rob Riemsma^*, Carol A. Forbes, Mayur M. Amonkar, Konstantinos Lykopoulos, Jose R. Diaz, Jos Kleijnen, Daniel W. Rea

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1263-1279
Journal	Current Medical Research and Opinion
Volume	28
Issue number	8
DOIs	https://doi.org/10.1185/03007995.2012.707643
Publication status	Published - Aug 2012

Keywords

Advanced or metastatic breast cancer
Aromatase inhibitor
First line treatment
HR
HER2+
Lapatinib

Access to Document

10.1185/03007995.2012.707643

Cite this

Riemsma, R., Forbes, C. A., Amonkar, M. M., Lykopoulos, K., Diaz, J. R., Kleijnen, J., & Rea, D. W. (2012). Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC). Current Medical Research and Opinion, 28(8), 1263-1279. https://doi.org/10.1185/03007995.2012.707643

Riemsma, Rob ; Forbes, Carol A. ; Amonkar, Mayur M. ; Lykopoulos, Konstantinos ; Diaz, Jose R. ; Kleijnen, Jos ; Rea, Daniel W. / Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC). In: Current Medical Research and Opinion. 2012 ; Vol. 28, No. 8. pp. 1263-1279.

@article{e6a4e640e4eb4865aaeefb91b1a7ff8e,

title = "Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)",

keywords = "Advanced or metastatic breast cancer, Aromatase inhibitor, First line treatment, HR, HER2+, Lapatinib",

author = "Rob Riemsma and Forbes, {Carol A.} and Amonkar, {Mayur M.} and Konstantinos Lykopoulos and Diaz, {Jose R.} and Jos Kleijnen and Rea, {Daniel W.}",

year = "2012",

month = aug,

doi = "10.1185/03007995.2012.707643",

language = "English",

volume = "28",

pages = "1263--1279",

journal = "Current Medical Research and Opinion",

issn = "0300-7995",

publisher = "Routledge/Taylor & Francis Group",

number = "8",

}

Riemsma, R, Forbes, CA, Amonkar, MM, Lykopoulos, K, Diaz, JR, Kleijnen, J & Rea, DW 2012, 'Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)', Current Medical Research and Opinion, vol. 28, no. 8, pp. 1263-1279. https://doi.org/10.1185/03007995.2012.707643

Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC). / Riemsma, Rob; Forbes, Carol A.; Amonkar, Mayur M.; Lykopoulos, Konstantinos; Diaz, Jose R.; Kleijnen, Jos; Rea, Daniel W.

In: Current Medical Research and Opinion, Vol. 28, No. 8, 08.2012, p. 1263-1279.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)

AU - Riemsma, Rob

AU - Forbes, Carol A.

AU - Amonkar, Mayur M.

AU - Lykopoulos, Konstantinos

AU - Diaz, Jose R.

AU - Kleijnen, Jos

AU - Rea, Daniel W.

PY - 2012/8

Y1 - 2012/8

KW - Advanced or metastatic breast cancer

KW - Aromatase inhibitor

KW - First line treatment

KW - HR

KW - HER2+

KW - Lapatinib

U2 - 10.1185/03007995.2012.707643

DO - 10.1185/03007995.2012.707643

M3 - Article

C2 - 22738819

VL - 28

SP - 1263

EP - 1279

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 8

ER -

Riemsma R, Forbes CA, Amonkar MM, Lykopoulos K, Diaz JR, Kleijnen J et al. Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC). Current Medical Research and Opinion. 2012 Aug;28(8):1263-1279. https://doi.org/10.1185/03007995.2012.707643